Andres N. Osorio
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Autophagy impairment is associated with enhanced satellite cell activation in muscle biopsies from younger late-onset Pompe disease patients.
Journal: Journal of neuropathology and experimental neurology
Published: July 27, 2025
Congenital myasthenic syndrome: is it time for a name change to genetic myasthenic syndrome?
Journal: Brain : a journal of neurology
Published: April 17, 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B).
Journal: Neuromuscular disorders : NMD
Published: September 16, 2024
Correction to: Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis.
Journal: Journal of neurology
Published: July 17, 2023
Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015-2022): 2022 interim analysis.
Journal: Journal of neurology
Published: November 15, 2022
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey.
Journal: Journal of neuromuscular diseases
Published: November 14, 2022
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder.
Journal: Nature communications
Published: October 15, 2020
Age and baseline values predict 12 and 24-month functional changes in type 2 SMA.
Journal: Neuromuscular disorders : NMD
Published: February 01, 2020
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study.
Journal: Journal of comparative effectiveness research
Published: January 31, 2020
Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry.
Journal: Journal of comparative effectiveness research
Published: August 16, 2019
Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease.
Journal: American journal of human genetics
Published: May 04, 2019
Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease.
Journal: American journal of human genetics
Published: November 02, 2018
Last Updated: 09/26/2026